Please check your internet connection and try again.
# Ecospirin (Aspirin, Enteric-Coated)
## Overview
Ecospirin is an enteric-coated formulation of aspirin, a non-steroidal anti-inflammatory drug (NSAID) with antiplatelet, analgesic, and antipyretic properties. The enteric coating is designed to delay absorption until the drug reaches the small intestine, potentially reducing gastric irritation.
## Primary Indications
* **Cardiovascular Prevention:** Primary and secondary prevention of myocardial infarction and stroke in patients with established cardiovascular disease or at high risk.
* **Pain and Inflammation:** Mild to moderate pain, fever, and inflammatory conditions (though lower doses are typically used for antiplatelet effects).
## Adult Dosing
* **Cardiovascular Prevention:** Typically 75 mg to 100 mg once daily. Higher doses (e.g., 325 mg) may be used in specific acute cardiovascular events or post-procedure.
* **Pain and Inflammation:** Doses range from 325 mg to 650 mg every 4 to 6 hours as needed, up to a maximum of 4000 mg per day. However, for chronic inflammatory conditions, higher doses may be prescribed under strict medical supervision.
## Pediatric Dosing
* **Fever and Pain:** Dosing is weight-based, typically 10-15 mg/kg/dose every 4-6 hours. **Aspirin should generally be avoided in children and adolescents with viral illnesses due to the risk of Reye's syndrome.** Specific pediatric indications and dosing should be guided by a healthcare provider.
## Dose Adjustments
* No specific dose adjustments are typically required for renal or hepatic impairment, but caution is advised, especially in severe dysfunction.
## Contraindications
* Hypersensitivity to aspirin, salicylates, NSAIDs, or any component of the formulation.
* Active peptic ulcer disease or gastrointestinal bleeding.
* History of asthma, urticaria, or other allergic-type reactions after aspirin or NSAID use.
* Children and adolescents with viral infections (risk of Reye's syndrome).
* Severe hepatic or renal impairment.
* Third trimester of pregnancy.
## Adverse Effects
* **Gastrointestinal:** Dyspepsia, heartburn, nausea, vomiting, abdominal pain, gastritis, peptic ulceration, GI bleeding.
* **Hematologic:** Increased bleeding time, bruising, epistaxis, menorrhagia.
* **Hypersensitivity:** Bronchospasm (especially in asthmatics), urticaria, angioedema.
* **Other:** Tinnitus (especially at higher doses), dizziness, headache.
## Key Drug Interactions
* **Anticoagulants (e.g., warfarin, heparin, DOACs):** Increased risk of bleeding.
* **Other NSAIDs and COX-2 Inhibitors:** Increased risk of GI toxicity and bleeding.
* **Corticosteroids:** Increased risk of GI ulceration and bleeding.
* **Selective Serotonin Reuptake Inhibitors (SSRIs):** Increased risk of bleeding.
* **Methotrexate:** Increased risk of methotrexate toxicity.
* **Antihypertensives (e.g., ACE inhibitors, ARBs, diuretics):** Reduced antihypertensive effect.
* **Uricosuric agents (e.g., probenecid):** Reduced uricosuric effect.
## Monitoring
* **Signs of bleeding:** Monitor for bruising, melena, hematemesis, epistaxis.
* **Gastrointestinal symptoms:** Assess for dyspepsia, abdominal pain.
* **Renal function:** Especially in patients with pre-existing renal disease or those on concomitant nephrotoxic agents.
* **Tinnitus:** May indicate toxicity, particularly at higher doses.
## Clinical Pearls
* The enteric coating delays absorption, which may reduce immediate gastric upset but does not eliminate the risk of GI bleeding.
* For acute cardiovascular events (e.g., suspected MI), non-enteric coated aspirin is typically preferred for faster absorption.
* Patients should be advised to report any signs of bleeding or severe gastrointestinal distress.
* Avoid concomitant use with other NSAIDs unless specifically advised by a healthcare provider.
* Use with caution in patients with asthma, nasal polyps, and hepatic or renal impairment.
***
*Disclaimer: This information is intended for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider and review the current prescribing information for any medication before use.*
